SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

14 Nov 2013 07:00

RNS Number : 9770S
Devro PLC
14 November 2013
 



For immediate release

14 November 2013

 

 

Devro plc

("the Group")

 

Interim Management Statement

 

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today provides an Interim Management Statement covering the period from 1 July 2013 to date.

 

Revenue continued to grow helped by the full impact of price increases implemented in the first half with sales volumes unchanged against the same period last year. Trading profits and margins have improved in the second half as new capacity at the Czech plant has come on stream.

Sales have been strong in emerging markets, most notably Latin America, China and South East Asia. Germany and Japan continued to grow volumes across all major product categories. Developed markets such as the UK, continental Europe, Australia and North America traded more slowly than prior year and below our expectations.

Select, the innovative thin walled casing introduced in 2010 to replace top quality sheep gut, continues to make a significant contribution to sales. In the year to date Select accounts for 8% of all sales in the Group. There continue to be good opportunities for new sales.

Manufacturing operations ran well with the investment at the Czech plant now complete and production at full capacity.

The Board has approved capital expenditure to construct a new manufacturing hall at our site in South Carolina, USA. This £40m project, which will be funded from the Group's existing facilities and future cash flow, will enable the business to reduce manufacturing costs by c.£8m pa from 2016 onwards, with full benefits expected in 2017. This investment is part of our continuing manufacturing improvement programme which will further enhance profits for sales into the Americas.

As mentioned at the interims, the Group is actively evaluating options for expansion of capacity through an investment in China and we expect to report on this in early 2014.

Hide prices are higher than the prior year although the rate of increase has significantly slowed compared with the increases experienced in the last 18 months.

The Japanese yen has devalued by 20% against prior year although the impact on 2013 has been minimised through forward hedging. In 2014, based on current exchange rates, we estimate that profits will be adversely affected by approximately £3m as current hedging arrangements unwind.

Gross debt is broadly in line with the level at the half year and continues to be well within the banking facilities.

 

Outlook

 

In light of unchanged sales volumes and weakness in some developed markets since 1st July, the Board now expects the outcome for 2013 to be towards the lower end of market expectations.

 

The Board remains confident in the longer term opportunities for supplying a dynamic and growing global market for edible casings.

 

For further information, please contact:

Devro plc

 

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

Tel No: 0207 182 4960

 

Buchanan

 

Charles Ryland / Sophie McNulty / Clare Akhurst

 

 

Tel No: 020 7466 5000

Further information on Devro can be found on the company's website: www.devro.com

As previously announced, Devro will be holding an investor presentation to provide an update on the Group's investment programme today at 4.00pm. The presentation will be available on the company's website shortly thereafter. No new material information will be disclosed during the presentation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMMNFZGFZM
Date   Source Headline
6th Oct 20157:00 amRNSCompletion of acquisition
6th Aug 20153:51 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSINTERIM RESULTS
27th Jul 20152:53 pmRNSListing Rule 9.6.14(R) Disclosure
10th Jul 20157:00 amRNSAcquisition
9th Jun 201511:43 amRNSHolding(s) in Company
1st Jun 20157:00 amRNSTotal Voting Rights
28th May 20152:44 pmRNSHolding(s) in Company
28th May 20152:41 pmRNSHolding(s) in Company
26th May 20158:16 amRNSBlock Listing Six Monthly Return
7th May 20155:10 pmRNSDirector/PDMR Shareholding
29th Apr 20154:15 pmRNSResult of AGM
29th Apr 20157:00 amRNSTrading Update
27th Mar 20157:00 amRNSChange of Auditor
27th Mar 20157:00 amRNS2014 Annual Report
26th Mar 20154:00 pmRNSDirector/PDMR Shareholding
5th Mar 20153:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20152:34 pmRNSDirector Dealings
3rd Mar 20157:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
3rd Dec 20144:19 pmRNSBlock Listing Six Monthly Return
21st Oct 201411:27 amRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSInterim Management Statement
6th Oct 20141:39 pmRNSHolding(s) in Company
29th Aug 201411:23 amRNSTotal Voting Rights
7th Aug 20149:04 amRNSHolding(s) in Company
1st Aug 20142:38 pmRNSDirector/PDMR Shareholding
30th Jul 20147:00 amRNS2014 Interim Results
19th Jun 201410:03 amRNSHolding(s) in Company
10th Jun 20145:00 pmRNSDirector/PDMR Shareholding
30th May 201411:18 amRNSHolding(s) in Company
30th May 20147:00 amRNSTotal Voting Rights
29th May 201410:13 amRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSBlock Listing Six Monthly Return
16th May 201411:01 amRNSDirector/PDMR Shareholding
15th May 20149:00 amRNSConfirmation of Board Change
13th May 20145:16 pmRNSDirector/PDMR Shareholding
8th May 201411:49 amRNSHolding(s) in Company
7th May 20147:00 amRNSFurther Information on US Private Placement
1st May 20142:12 pmRNSDirector Dealings
30th Apr 20144:48 pmRNSResult of AGM
30th Apr 20148:27 amRNSTotal Voting Rights
30th Apr 20147:01 amRNSAppointment of Chairman
28th Apr 20147:00 amRNSInterim Management Statement
24th Apr 20144:43 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSAnnual Financial Report
21st Mar 201411:12 amRNSAdditional Listing
17th Mar 20142:54 pmRNSHolding(s) in Company
10th Mar 201410:54 amRNSHolding(s) in Company
10th Mar 201410:26 amRNSHolding(s) in Company
5th Mar 20144:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.